Clinical Trial Update: Clinical Study of Lamotrigine to Treat Newly Diagnosed Typical Absence Seizure in Children and Adolescents [Phase 3]

View source ↗

Summary

Phase 3 clinical study of lamotrigine for newly diagnosed typical absence seizures in children and adolescents has completed, with results posted in 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Absence Seizures
• Epilepsy

Drugs mentioned

• Lamotrigine (lamotrigine)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Epilepsy | Phase 3 | Status: COMPLETED | Results posted: 2014-08-27